Evidence map›Paper›PMID 18424702›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2008

Conserved mycobacterial lipoglycoproteins activate TLR2 but also require glycosylation for MHC class II-restricted T cell activation.

Peter A Sieling, Preston J Hill, Karen M Dobos, Kerry Brookman, Andrew M Kuhlman, Mario Fabri, Stephan R Krutzik, Thomas H Rea, Darragh G Heaslip, John T Belisle and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Evolution of Drug-ResistantFrontiers in microbiology · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. The sweet tooth of bacteria: common themes in bacterial glycoconjugates.Microbiology and molecular biology reviews : MMBR · 2014
    Review
  15. Bacterial protein-O-mannosylating enzyme is crucial for virulence of Mycobacterium tuberculosis.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. T cells in mycobacterial infection and disease.Current opinion in immunology · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Peter A SielingDivision of Dermatology, David Geffen School of Medicine at UCLA, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
Preston J Hill
Karen M Dobos
Kerry Brookman
Andrew M Kuhlman
Mario Fabri
Stephan R Krutzik
Thomas H Rea
Darragh G Heaslip
John T Belisle
Robert L Modlin
Colorado State University · USUniversity of California, Los Angeles · USUniversity of Southern California · US

Funding

Molecular Analysis of the Host Immune Response in LeprosyR01AI022553 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROBERT L MODLIN · 1989 to 2026
$15.7M
ROLE OF TOLL-LIKE RECEPTORS IN SKINR37AI047868 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODLIN, ROBERT L · 2000 to 2009
$2.9M
Divergence of Phagocytic and Antimicrobial Programs in LeprosyR01AI047868 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODLIN, ROBERT L · 2010 to 2014
$2.4M
TUBERCULOSIS RESEARCH MATERIALS AND VACINE TESTINGN01AI075320 · NIAID · COLORADO STATE UNIVERSITY-FORT COLLINS · 1997 to 2004
$980k
IMMUNOREGULATORY T-LYMPHOCYTES IN LEPROSY SKIN LESIONSR22AI022553 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MODLIN, ROBERT L · 1986 to 1991
–
NIAID NIH HHS AI 22553NIAID NIH HHS AI 47868NIAID NIH HHS N01 AI 75320NIAID NIH HHS R01 AI022553NIAID NIH HHS R01 AI047868NIAID NIH HHS R37 AI047868
6 · The paper itself

Abstract

CD4(+) T cell clones derived from a leprosy lesion and patient blood were used to monitor the isolation and identification of an Ag associated with the self-limited form of the disease. Biochemical purification and genetic analysis identified the T cell Ag as a conserved mycobacterial lipoglycoprotein LprG. LprG-mediated activation of CD4(+) T cells required specific MHC class II restriction molecules and intracellular processing. Although LprG activated TLR2, this alone was not sufficient to stimulate or inhibit T cell activation. A striking finding was that the carbohydrate moieties of LprG were required for optimal T cell activation, because recombinant LprG produced in Escherichia coli, or recombinant LprG produced in Mycobacterium smegmatis and digested by alpha-mannosidase, did not activate T cells. This study demonstrates that the universe of bacterial T cell Ags includes lipoglycoproteins, which act as TLR2 ligands but also require glycosylation for MHC class II-restricted T cell activation in vivo.

Indexed as

alpha-MannosidaseAntigens, BacterialCarbohydratesCD4-Positive T-LymphocytesEscherichia coliHistocompatibility Antigens Class IIHumansLipoproteinsLymphocyte ActivationMycobacteriumRecombinant ProteinsToll-Like Receptor 2alpha-MannosidaseAntigens, BacterialCarbohydratesHistocompatibility Antigens Class IILipoproteinsRecombinant ProteinsTLR2 protein, humanToll-Like Receptor 2

Identifiers

PMID18424702
PMCPMC2710377
OpenAlexW1843776760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.